PMID- 36438444 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221129 IS - 2673-561X (Electronic) IS - 2673-561X (Print) IS - 2673-561X (Linking) VI - 3 DP - 2022 TI - TRPV1 in dorsal root ganglion contributed to bone cancer pain. PG - 1022022 LID - 10.3389/fpain.2022.1022022 [doi] LID - 1022022 AB - Tumor growth in situ or bone metastases in cancer patients all can induce bone cancer pain. It is frequently occurred in patients with breast, prostate, and lung cancer. Because of the lack of effective treatment, bone cancer pain causes depression, anxiety, fatigue, and sleep disturbances in cancer patients, disrupts the daily quality of life, and results in huge economic and psychological burden. Over the past years, transient receptor potential channels (TRPs), especially TRP vanilloid 1 (TRPV1) in dorsal root ganglion (DRG), have been considered to be involved in bone cancer pain. The characteristic of TRPV1 had been well studied. The mechanisms under TRPV1 regulation in DRG with bone cancer pain are complex, including inflammatory mediators, endogenous formaldehyde, and other mechanisms. In the present review, we summarize the role and potential mechanism of TRPV1 in DRG in bone cancer pain. As the primary sensory neurons, targeting the TRPV1 channel in DRG, might have fewer side effects than in central. We hope systematically understand of TRPV1 modulation in DRG will bring more effective strategy. CI - (c) 2022 Chen, Li, Hao and Liu. FAU - Chen, Wen AU - Chen W AD - International Acupuncture and Moxibustion Innovation Institute, Beijing University of Chinese Medicine, Beijing, China. AD - School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China. FAU - Li, Hongping AU - Li H AD - International Acupuncture and Moxibustion Innovation Institute, Beijing University of Chinese Medicine, Beijing, China. FAU - Hao, Xiaowan AU - Hao X AD - International Acupuncture and Moxibustion Innovation Institute, Beijing University of Chinese Medicine, Beijing, China. FAU - Liu, Cunzhi AU - Liu C AD - International Acupuncture and Moxibustion Innovation Institute, Beijing University of Chinese Medicine, Beijing, China. AD - School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China. LA - eng PT - Journal Article PT - Review DEP - 20221109 PL - Switzerland TA - Front Pain Res (Lausanne) JT - Frontiers in pain research (Lausanne, Switzerland) JID - 9918227269806676 PMC - PMC9682177 OTO - NOTNLM OT - TRPV1 OT - bone cancer pain OT - dorsal root ganglion OT - mechanisms OT - regulation COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/11/29 06:00 MHDA- 2022/11/29 06:01 PMCR- 2022/11/09 CRDT- 2022/11/28 04:17 PHST- 2022/08/18 00:00 [received] PHST- 2022/10/17 00:00 [accepted] PHST- 2022/11/28 04:17 [entrez] PHST- 2022/11/29 06:00 [pubmed] PHST- 2022/11/29 06:01 [medline] PHST- 2022/11/09 00:00 [pmc-release] AID - 10.3389/fpain.2022.1022022 [doi] PST - epublish SO - Front Pain Res (Lausanne). 2022 Nov 9;3:1022022. doi: 10.3389/fpain.2022.1022022. eCollection 2022.